Insights

Gathering insights about PTP…

Similar companies to PTP

PTP Tech Stack

PTP uses 8 technology products and services including Audacity, Amazon Web Services, Five9, and more. Explore PTP's tech stack below.

Audacity
Audio, Video, Graphics
Amazon Web Services
Cloud Hosting
Five9
Contact Center Solutions
Jenkins
Continuous Integration
Microsoft Excel
Editors
Google Fonts API
Font Scripts
Spring Boot
Frameworks And Libraries
JavaScript
Programming Languages

Media & News

Head to Head Contrast: Petros Pharmaceuticals (NASDAQ:PTPI) vs. Statera Biopharma (NASDAQ:STAB)
Profitability This table compares Statera Biopharma and Petros Pharmaceuticals' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Statera Biopharma N/A N/A N/A Petros Pharmaceuticals N/A -78.22% -23.50% Insider and Institutional Ownership 12.3% of Petros Pharmaceuticals shares are owned by institutional investors. 5.5% of Statera Biopharma shares
Dec 03, 2025 | www.defenseworld.net
Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Company's Equity Position
NEW YORK, NY / ACCESS Newswire / June 25, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces the strategic deconsolidation of its wholly owned subsidiary, Metuchen Pharmaceuticals LLC ("Metuchen"), including its wholly owned subsidiaries, Timm Medical Technologies, Inc. and Pos-T-Vac, LLC, from its consolidated balance sheet, effective beginning in its Quarterly Report on Form 10-Q for the quarter ending June 30, 2025. This move is expected to significantly improve Petros' financial position, increasing stockholders' equity and materially reducing consolidated debt.
Jun 25, 2025 | www.accessnewswire.com
Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets
The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces that it has received a staff determination letter from the Nasdaq Stock Market, LLC ("Nasdaq"), informing the Company that Nasdaq determined to suspend trading and delist the Company's common stock from Nasdaq. At the open of trading on Thursday, May 22, 2025, Petros' securities will be suspended on Nasdaq and are expected to begin trading on the OTC Markets under the ticker "PTPI".
May 21, 2025 | www.accessnewswire.com
Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer
With more than $10m in cash, and a significantly reduced burn rate, the Company is positioned to fully fund the development of its technology platform. NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces its partnership with Innolitics, a leading developer in the Software-as-a-Medical Device space.
May 20, 2025 | www.accessnewswire.com
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces it has implemented multiple enhancements to its developing AI platform, which is expected to improve processing and fraud detection and provide a better overall experience. The AI Platform is expected to be a key component of the Company's recently announced SaaS-based technology, integrating Petros' Software as a Medical Device ("SaMD") proprietary solution, which is being designed to help facilitate expanding access for established prescription drugs by bringing them over the counter.
May 06, 2025 | www.accessnewswire.com
Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again (MAHA) initiative NEW YORK, NY / ACCESS Newswire / May 1, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces a concerted effort toward evolving into a smart healthcare technology company through the development of a SaaS platform designed to complement its proprietary web application (also known as a Software as a Medical Device, or SaMD). The licensable platform is being designed to integrate key cloud-based components, including AI, electronic health records, cybersecurity and others to provide potential prescription treatments and pharmaceutical sponsors with a commercially viable and enterprise scaled platform.
May 01, 2025 | www.accessnewswire.com
Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms
Company's AI and Big Data technology positioned to drive strong industry collaboration Company also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today highlights President Trump's April 15, 2025 Executive Order, titled, "Lowering Drug Prices By Once Again Putting Americans First" (the "Executive Order"), as a demonstration that the Company's recent strategic shift is well timed to the current regulatory climate, where Petros believes it has already made significant advancements. Petros' development of its Big Data and AI-driven software-as-a-Medical Device platform presents an important opportunity for the pharmaceutical industry to contribute to the lowering of drug prices while utilizing an emerging, yet proven, methodology that conforms with FDA guidance to ensure a safe transition from Rx to OTC.
Apr 29, 2025 | www.accessnewswire.com

PTP's Email Address Formats

PTP uses at least 1 format(s):

PTP Email Formats	Example	Percentage
First.Last@ptpinc.com	John.Doe@ptpinc.com	94%
Last_First@ptpinc.com	Doe_John@ptpinc.com	4%
LastFirst@ptpinc.com	DoeJohn@ptpinc.com	1%
First_Last@ptpinc.com	John_Doe@ptpinc.com	1%

Frequently Asked Questions

Where is PTP's headquarters located?

PTP's main headquarters is located at 500 Capitol Malecón, Suite 2350. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is PTP's phone number?

You can contact PTP's main corporate office by phone at

+1-916-791-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PTP's stock symbol?

PTP is a publicly traded company; the company's stock symbol is PTPI.

What is PTP's official website and social media links?

PTP's official website is ptpinc.com and has social profiles on LinkedIn.

What is PTP's SIC code NAICS code?

PTP's SIC code is 6531 - Real Estate Agents and Managers NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does PTP have currently?

As of December 2025, PTP has approximately 355 employees across 6 continents, including North AmericaAsiaEurope. Key team members include Vp: Y. L.Director, Corporate Recruiting: Customer Experience, Cyber Security, Government: C. C.Director Of Engineering: M. T.. Explore PTP's employee directory with LeadIQ.

What industry does PTP belong to?

PTP operates in the IT Services and IT Consulting industry.

What technology does PTP use?

PTP's tech stack includes AudacityAmazon Web ServicesFive9JenkinsMicrosoft ExcelGoogle Fonts APISpring BootJavaScript.

What is PTP's email format?

PTP's email format typically follows the pattern of First.Last@ptpinc.com. Find more PTP email formats with LeadIQ.

When was PTP founded?

PTP was founded in 2004.

PTP

Q: What is PTP's official website and social media links?

PTP's official website is ptpinc.com. PTP has social profiles on LinkedIn.

Q: How many employees does PTP have currently?

PTP has approximately 355 employees.

Q: What technology does PTP use?

PTP's tech stack includes Yoast SEO, Vaadin, Genesys SIP, Google Voice, HTML.

IT Services and IT ConsultingCalifornia, United States201-500 Employees

PTP is a consulting firm wholly focused on helping organizations deliver strategic customer experience solutions that drive revenue. 

We provide strategy, implementation and support services across the most common Contact Center, CRM and Security technology platforms, and unlike most business consulting firms, we are fast, flexible, and performance-driven.